<DOC>
	<DOCNO>NCT02666547</DOCNO>
	<brief_summary>This study assess potential 68Ga-NODAGA-RGD evaluation neoangiogenesis patient follow neoplastic pathology a18F-FDG ( 18F-FET glioma ) indicate initial extension evaluation suspicion recurrent tumor .</brief_summary>
	<brief_title>68Ga-NODAGA-RGD PET/ CT Tumoral Neoangiogenesis</brief_title>
	<detailed_description>The purpose study ass value 68Ga-NODAGA-RGD PET/CT detection neoangiogenesis level neoplastic process , patient , compare 18F-FDG PET/CT ( tumor glioma ) 18F-FET PET/CT ( patient affect glioma ) determine respective diagnostic contribution every technique . Every patient undergo routine 18F-FDG ( 18F-FET ) PET/CT follow 68Ga-NODAGA-RGD PET / CT specific study within next 7 day . ( image procedure duration : 2h ) The criterion primary evaluation technique define : - On image PET/CT : SUVmax , SUVmoyen , VOI ( mL ) , SUV41 % ratio [ mean SUV pixel ≥ 41 % SUVmax ] lesion / SUV - On image CT : size lesion measure 3D ( axial , coronal sagittal ) , density Hounsfield unit ( HU ) The 18F-FDG/18F-FET 68Ga-NODAGA-RGD PET / CTs analyze first separately compare accord method describe analysis</detailed_description>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Age ≤ 85 year old Karnofsky index : ≥ 80 % Patients present neoplasic pathology , histologically proven , know express integrin αvβ3and 18FFDG ( 18FFETfor glioma ) indicate : ( 1 ) glioma ( WHO I , IIIV ) , ( 2 ) malignant melanoma , ( 3 ) cancer upper respiratory tract , ( 4 ) breast cancer , ( 5 ) bone metastasis , ( 6 ) ovarian cancer , ( 7 ) lung cancer , ( 8 ) nonHodgkinian malignant lymphoma extra lymphatic node extension , ( 9 ) neuroendocrine tumor , ( 10 ) pancreatic cancer , ( 11 ) oesophagus cancer , ( 12 ) stomach cancer . 10 patient include per type cancer . Informed consent sign Incapacity sign inform consent Pregnancy , breastfeed Age &lt; 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>68Ga-NODAGA-RGD</keyword>
	<keyword>18F-FDG</keyword>
	<keyword>18F-FET</keyword>
	<keyword>PET/CT</keyword>
	<keyword>neoangiogenesis</keyword>
</DOC>